| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Director | Common Stock | 1.62M | $45.4M | $28.04 | Nov 15, 2022 | By RiverVest Venture Fund IV, L.P. |
| SPRUCE BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 30K | May 25, 2023 | Direct | ||
| Reneo Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 17.5K | Jun 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RPHM | Reneo Pharmaceuticals, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| SPRB | SPRUCE BIOSCIENCES, INC. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| RPHM | Reneo Pharmaceuticals, Inc. | May 8, 2023 | 1 | $1M | 4 | May 10, 2023 | Director |
| SPRB | SPRUCE BIOSCIENCES, INC. | Feb 16, 2023 | 2 | $2M | 4 | May 16, 2023 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Nov 11, 2022 | 3 | -$5.96M | 4 | Nov 15, 2022 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
| RPHM | Reneo Pharmaceuticals, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| SPRB | SPRUCE BIOSCIENCES, INC. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |
| SPRB | SPRUCE BIOSCIENCES, INC. | May 20, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |